Company intelligence / Profile preview

Hisense

Qingdao, Shandong, Chinahisense-usa.com ↗

Ownership: Public · 600060
Employees: ~80000
Development stage: Other

Overview

Hisense’s healthcare divisions have launched commercialized color Doppler ultrasound diagnostic instruments and 4K endoscope monitors. In biotech, “Hisense Bio” develops regenerative therapies for dental diseases with patent filings but no disclosed late-stage clinical results.

Therapeutic areas: Infectious DiseasesOther
Modalities: DeviceBiologic
Industry: Medical Imaging

Partnerships

Not specifically detailed in search results. Some device supply relationships with Chinese hospitals/endoscope manufacturers are mentioned.

Beyond the preview

Go deeper on Hisense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hisense.

Explore the full profile